ClinicalTrials.gg
CompletedNCT03350776EPOCKUpdated Jun 19, 2020

Practices and Organizations Related to Emerging Occupations of Care (EPOCK) Coordination in Oncology

An observational study in Care Coordination in Oncology, sponsored by University Hospital, Bordeaux. Completed at 10 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-06-19.

Sponsored by University Hospital, Bordeaux · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
960
Ages
18 Years and older
Sex
All
01

Study summary

Several stakeholders are implied in cancer care pathways and there is a need for coordinating their actions. New occupations of care coordination have thus emerged. However, the conditions of their efficiency have been too few reported and included discrepancies between reports. In this context, the main objective is to propose a modeling of care coordination and associated emerging occupations (nurse-based) by comparing theoretical expected outcomes to professionals, patients and caregivers representations.

Read the detailed description

Several stakeholders are implied in cancer care pathways and there is a need to coordinate their actions. New occupations of care coordination have thus emerged, such as nurse coordinator in France (IDEC: Infirmière de Coordination). However, the conditions of their efficiency are not well known. Moreover, several other complementary approaches and nurse occupations have to be identified because of their contribution to care coordination (IDE TAS, IPO, IDE AMA, IDE-CO, IDE HAD-CAD, IDE ETP)*. Finally, all together, these interventions of care coordination appeared as complex and asked for a theoretical model. Because of this high variability of the practices, without an underlying model, the impact of care coordination on patient quality of life, safety and efficiency of care is difficult to assess. In this context, the main objective is to propose a modeling of care coordination and associated emerging occupations by comparing theoretical expected outcomes to professionals, patients and caregivers representations.

The pilot observational study is based on three distinct stages: (1) the definition of care coordination in oncology using a literature review and a Delphi consensus study; (2) the description of practices, contexts, perceptions and attitudes related to care coordination occupations in oncology using a qualitative and a cross-sectional quantitative survey; (3) the comparison of the practices to the theoretical model to propose a modeling of care coordination occupations in oncology.

02

Conditions studied

  • Care Coordination in Oncology

Keywords

  • Neoplasm
  • Chronic disease
  • Complex cases
  • Care coordination
  • Oncologic nursing
  • Theoretical model
03

In context

Neoplasms

10,818 studies on the registry are indexed under Neoplasms; 2,324 are open to participants now.

This study's enrollment of 960 is above the median of 200 across 2,638 observational studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

University Hospital, Bordeaux is the lead sponsor of 807 studies on the registry; 198 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Four samples :

  • Professionals of cancer care coordination
  • Cancer patients
  • Family caregivers of the selected patients
  • Professionals working with professionals of care coordination

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • For health institutions: public or private institutions in which nurses contributing to care coordination. Each institution will be associated with one type of coordination occupation, even if other healthcare workers contribute to care coordination in the same institution.
  • For professionals of care coordination: nurses contributing to care coordination in oncology (IDEC , IDE TAS, IPO, IDE AMA, IDE-CO, IDE HAD-CAD or IDE ETP)
  • For professionals working with professionals of care coordination:

    • Medical and non-medical healthcare professionals (oncologist, surgeon, nurses...), administrative professionals (secretary...), professionals of supportive care (psychologists, social workers...) and volunteers in patient organizations.
    • Private practitioners: general practitioner, private nurses, pharmacist
  • For the patients : adults under supervision of the selected professionals of care coordination for at least four weeks and able to express themselves
  • For the caregivers: family caregivers of the selected patients.

Exclusion criteria

Exclusion Criteria:

  • For health institutions: private healthcare networks, territorial support platforms, home-based care providers, healthcare houses
  • For professionals of care coordination: coordinating medical doctors of care networks, coordinating medical doctors of hospital care at home, practitioners of regional cancer networks.
  • For the patients: \<18 years old
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
960 participants (actual)
Patient registry
No

Interventions

  • BehavioralCare coordination

    Care coordination and associated emerging occupations by comparing theoretical expected outcomes to professionals, patients and caregivers representations

06

What researchers measure

Primary outcomes

  1. Modeling of care coordination in Oncology in France

    Constitutive elements of modelling of care coordination in oncology in France (qualitative analysis)

    Time frame: During the whole period (36 months: from Month 1 to Month 36)

Secondary outcomes

  1. Care coordination profesionals quality of life

    Three scores : perceived organizational support, role conflict and commitment to the organization

    Time frame: Quantitative cross sectional survey (from Month 10 to Month 29)

  2. Satisfaction with care coordination for profes professionals working with professionals of care coordination

    Score of satisfaction

    Time frame: Quantitative cross sectional survey (from Month 10 to Month 29)

  3. Patients quality of life and satisfaction with care coordination

    Score of satisfaction and score of quality of life (measured with the European Organization for Research and Treatment (EORTC) quality of life questionnaire)

    Time frame: Quantitative cross sectional survey (from Month 10 to Month 29)

  4. Caregivers burden with care coordination

    Score of burdean (Zarit Burden Interview) with care coordination

    Time frame: Quantitative cross sectional survey (from Month 10 to Month 29)

  5. Caregivers satisfaction with care coordination

    Score of satisfaction with care coordination

    Time frame: Quantitative cross sectional survey (from Month 10 to Month 29)

07

Study locations

10 sites
  • Institut Sainte Catherine
    Avignon, France
  • CHU de Bordeaux
    Bordeaux, France
  • Clinique Tiivoli Ducos
    Bordeaux, France
  • CH Sud Gironde
    Langon, France
  • CH de Libourne
    Libourne, France
  • Institut Curie
    Paris, France
  • Institut de Cancérologie de la Loire
    Saint-Priest, France
  • HAD Bagatelle
    Talence, France
  • CHU de Toulouse
    Toulouse, France
  • Institut Claudius Regaud
    Toulouse, France
08

References and documents

Publications

  • Colombani F, Sibe M, Kret M, Quintard B, Ravaud A, Saillour-Glenisson F. EPOCK study protocol: a mixed-methods research program evaluating cancer care coordination nursing occupations in France as a complex intervention. BMC Health Serv Res. 2019 Jul 12;19(1):483. doi: 10.1186/s12913-019-4307-7. PubMed 31299966 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2018 to primary completion in Oct 2019, 17 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2017
First posted
Nov 22, 2017
StartActual
Apr 17, 2018
Primary completionActual
Oct 2, 2019
CompletionActual
Oct 30, 2019
Last update
Jun 19, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 19, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03350776
Responsible party
Sponsor
First posted
Nov 22, 2017
Start date
Apr 17, 2018
Primary completion
Oct 2, 2019
Completion
Oct 30, 2019
Last update
Jun 19, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion